Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
927.15
3.50
(0.38%)
< Home
< Back
Natco Pharma Ltd. News
>>
Natco Pharma informs about press release
>>
Natco Pharma’s arm launches NAT-LENALIDOMIDE Capsules
>>
Natco Pharma informs about disclosure
>>
Natco Pharma informs about investor presentation
>>
Natco Pharma informs about newspaper advertisement
>>
NATCO Pharma informs about outcome of board meeting
>>
Natco Pharma gains on transferring Lenalidomide ANDA to Arrow International
>>
Natco Pharma transfers Lenalidomide ANDA to Arrow International
>>
Natco Pharma jumps after its marketing partner gets approval for Carfilzomib Vials
>>
Natco Pharma informs about press release
<<
<
18
19
20
...52
>
>>